MedTrace Logo

Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19

NCT05049213 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2023-08-15

No results posted yet for this study

Summary

The goal of this study is to recruit confirmed Covid-19 patients, to evaluate whether the topical anti-septic can improve clinical outcome in early Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection. During the global pandemic period, an effective and highly available method once be identified, it will reduce the risk of disease transmission and lower the medical burden.

Conditions

  • Covid19
  • SARS-CoV 2 Infection

Interventions

DRUG

Carrageenan nasal spray and 1% PVP- mouthwash and gargle

Day1 to Day7 1. Intranasal spray 3 times/day, 2\~3 spray/nostril/per time 2. Oral gargling 3 times/day, 15cc/per time

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Te-Huei Yeh, MD-PhD · National Taiwan University Hospital, Department of Otolaryngology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-24
Primary Completion
2022-08-01
Completion
2022-08-01

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05049213 on ClinicalTrials.gov